Neuron BPh and Fundación MEDINA join forces to publicize their technologies and pre-clinical research services for the pharmaceutical industry conducting join promotional activities. The agreement will increase the synergies between the two organizations especially in the development of new drug candidates and innovative therapies. Both organizations, based in the PTS of Granada, decided to extend their offer to integrated services and develop preclinical research program counting with the best professionals of the sector. Fundación MEDINA has 50 years of experience in the discovery of new drugs from natural products. Additionally, through its platform of AMES assays, MEDINA offers a wide range of tests for the evaluation of cardiovascular risks and secondary effects derivate from the drug metabolisms. As far as Neuron BPh is concerned, through its Bio Pharma division, the company offers preclinical research services such as Rodent in Vitro assays, security tests and zebrafish tests. Neuron strengthen its growth through partnerships and collaborations with companies from the pharmaceutical sector and developing new products to enhance the commercial activity of the company.